[1] |
Wang Shimeng, Ma Yingji, Wu Ying, Liu Xiaodan, Wang Wei.
Effects of HBV infection on liver metastasis of tumor: A meta-analysis
[J]. Clinical Focus, 2021, 36(5): 389-394.
|
[2] |
Wang Yuanyuan, Cheng Ning, Lin Haiyan.
Correlation of serum sST2 and liver function, platelet level and Ishak score in chronic hepatitis B patients
[J]. Clinical Focus, 2021, 36(11): 976-980.
|
[3] |
Wang Xiaoling, Shen Lixian, Li Huiwen, Zhang Yaqin, Li Yao, Wu Shuna.
Changes and significance of CD86 expression on pDCs in patients with acute hepatitis B
[J]. Clinical Focus, 2020, 35(8): 719-723.
|
[4] |
Zhu Ping1, Lu Yufeng2a, Wang Li3, Wang Hong2b, Yang Li2b, .
Association study between liver inflammation and HBeAg quantification
[J]. Clinical Focus, 2019, 34(7): 637-640.
|
[5] |
Xu Manman1, Cheng Kailiang2, Qiu Qian3, Zhao Xinyu2, Duan Zhongping1, Wang Li2, Chen Yu1.
Factors associated with adherence to antiviral therapy in patients with HBV-related cirrhosis
[J]. Clinical Focus, 2018, 33(11): 950-955.
|
[6] |
Liu Xiaomeng, Zhao Caiyan.
Clinical advances in infectious diseases in 2017
[J]. Clinical Focus, 2018, 33(1): 60-65.
|
[7] |
Xiong Liangwei, Zhang Xianggui, Zhang Wei, Tang Jieyin.
Effectiveness and safety on immunosuppressant combined with nucleoside analogues therapy in hepatitis B virusassociated glomerulonephritis patients:a metaanalysis
[J]. Clinical Focus, 2017, 32(7): 613-617.
|
[8] |
Kong Ming, Shi Hongbo, Bai Li, Yao Jia, Chen Yu, Duan Zhongping.
Characteristics of plasma amino acids in patients with HBVrelated chronic hepatitis, cirrhosis and acute on chronic liver failure
[J]. Clinical Focus, 2016, 31(7): 732-735,740.
|
[9] |
Li Jun,Han Tao.
2015 Chinese Practice Guidelines of Chronic Hepatitis B: an update
[J]. Clinical Focus, 2016, 31(7): 701-704.
|
[10] |
Shen Chuan1, Wang Jing2, Zhao Caiyan1, Zhang Wenhong2.
Functional cure of chronic hepatitis B: current status and perspectives
[J]. Clinical Focus, 2016, 31(7): 697-700.
|
[11] |
Wang Guixia;Zeng Yue;Meng Huanghua.
Effect of entecavir therapy on chronic hepatitis B patients for 48 weeks
[J]. Clinical Focus, 2015, 30(8): 899-902.
|
[12] |
Li Shoujuan;Wang Li;Wu Bei;Zhu Li;Duan Meng;Chen Zhu.
Clinical observation of double plasma molecular adsorption system combined with plasma exchange in treatment of severe hepatitis B
[J]. Clinical Focus, 2015, 30(7): 781-784.
|
[13] |
Wang Anna;Feng Xiaokun;Yan Xiaodong;Shi Ying;Chen Dexi.
Research on relationship between autophagy and hepatitis B virus replication
[J]. Clinical Focus, 2015, 30(2): 210-213.
|
[14] |
Chen Li;Huang Xiaoping;Huang Yan;Sun Wei;Zhu Haichao;Gan Jianhe.
Th17,Treg and Th17/Treg in peripheral blood of patients with hepatitis B virus-related subacute-on-chronic liver failure and their relevance with model for end-stage liver disease score
[J]. Clinical Focus, 2015, 30(12): 1382-1385.
|
[15] |
LIU Ya;WU Jin-ming;CHEN Mei-qin.
Efficacy of entecavir for 96 weeks in patients with hepatitis B virus-related cirrhosis and chronic hepatitis B
[J]. Clinical Focus, 2014, 29(6): 672-675.
|